, a bio/informatics shared resource is still "open for business" - Visit the CDS website

Preliminary Testing of a Patient-Reported Outcome Measure for Recurrent or Metastatic Head and Neck Cancer.

Jackson LK, Deng J, Ridner SH, Gilbert J, Dietrich MS, Murphy BA
Am J Hosp Palliat Care. 2016 33 (4): 313-20

PMID: 25667146 · DOI:10.1177/1049909115569591

OBJECTIVE - We describe development and preliminary testing of Vanderbilt Head and Neck Symptom Survey-Recurrent/Metastatic (VHNSS-RM) to assess residual symptoms, tumor-related symptoms, and side effects from therapy.

METHODS - Items were identified through patient and provider interviews. Card sort selected high-yield and high-impact items. The VHNSS-RM was administered to 50 patients with recurrent/metastatic head and neck cancer (RMHNC).

RESULTS - The VHNSS-RM includes 12 unique symptoms (diet change, tongue movement affecting speech/swallowing, face/neck swelling, neck/jaw cramping, bad breath, drooling, wound drainage/pain/odor, nasal congestion/drainage, eyes watering, face/tongue/ear/scalp numbness, headaches, and confusion) and 7 unique psychosocial issues (burden to family/friends, lost independence, fear, embarrassment, mood swings, stress, and boredom).

CONCLUSIONS - The VHNSS-RM contains 35 physical and 12 psychosocial issues. The VHNSS-RM is feasible and not overly burdensome. Nineteen unique items may improve palliation to patients with RMHNC.

© The Author(s) 2015.

MeSH Terms (12)

Aged Chemoradiotherapy Cross-Sectional Studies Female Head and Neck Neoplasms Humans Male Middle Aged Neoplasm Metastasis Patient Reported Outcome Measures Severity of Illness Index Socioeconomic Factors

Connections (1)

This publication is referenced by other Labnodes entities: